Azenta, Inc. AZTA

Company Overview

Azenta, Inc. is a life sciences and biotechnology infrastructure company focused on sample management, cold-chain logistics, genomic services, and laboratory automation solutions. The company operates primarily within the life sciences tools and services industry, serving pharmaceutical companies, biotechnology firms, academic research institutions, healthcare organizations, and clinical laboratories. Azenta’s business model centers on enabling research, drug discovery, biologics development, and precision medicine workflows through integrated laboratory services and automated sample management technologies.

The company’s principal revenue drivers include its Sample Management Solutions and Multiomics businesses, which provide biorepository services, automated storage systems, genomic sequencing, synthetic biology support, and cold-chain logistics capabilities. Azenta evolved from Brooks Automation, Inc., a semiconductor automation company founded in 1978, and transitioned strategically toward life sciences over the past decade through acquisitions and divestitures. Following the sale of its semiconductor automation business in 2022, the company rebranded as Azenta to reflect its focus on life sciences infrastructure and research enablement. Public filings and investor materials consistently identify the company’s strategic differentiation as its integrated combination of automated sample storage, biologic sample handling, and genomic analysis capabilities.